Ceragenins are active against drug-resistant Candida auris clinical isolates in planktonic and biofilm forms
Evaluating the potential of residual Pap test fluid as a resource for the metaproteomic analysis of the cervical-vaginal microbiome
The FDA’s 510(k) Submission Process; Common Reasons for Receiving a Refuse-to-Accept (RTA) Decision
FDA refuse to accept
A 510(k) submission is made to the U.S. Food and Drug Administration (FDA) to demonstrate that a potential new medical device to be marketed is as safe and effective as a product that has already become legally available.
However, before...